دورية أكاديمية

Pembrolizumab in combination with nab-paclitaxel for the treatment of patients with early-stage triple-negative breast cancer – A single-arm phase II trial (NeoImmunoboost, AGO-B-041)

التفاصيل البيبلوغرافية
العنوان: Pembrolizumab in combination with nab-paclitaxel for the treatment of patients with early-stage triple-negative breast cancer – A single-arm phase II trial (NeoImmunoboost, AGO-B-041)
المؤلفون: Fasching, Peter A., Hein, Alexander, Kolberg, Hans-Christian, Häberle, Lothar, Uhrig, Sabrina, Rübner, Matthias, Belleville, Erik, Hack, Carolin C., Fehm, Tanja N., Janni, Wolfang, Hartmann, Arndt, Erber, Ramona, Theuser, Anna-Katharin, Brucker, Sara Y., Hartkopf, Andreas D., Untch, Michael
المصدر: European Journal of Cancer ; volume 184, page 1-9 ; ISSN 0959-8049
بيانات النشر: Elsevier BV
سنة النشر: 2023
المجموعة: ScienceDirect (Elsevier - Open Access Articles via Crossref)
نوع الوثيقة: article in journal/newspaper
اللغة: English
DOI: 10.1016/j.ejca.2023.01.001
الإتاحة: https://doi.org/10.1016/j.ejca.2023.01.001Test
https://api.elsevier.com/content/article/PII:S0959804923000072?httpAccept=text/xmlTest
https://api.elsevier.com/content/article/PII:S0959804923000072?httpAccept=text/plainTest
حقوق: https://www.elsevier.com/tdm/userlicense/1.0Test/ ; http://creativecommons.org/licenses/by/4.0Test/
رقم الانضمام: edsbas.55201FF8
قاعدة البيانات: BASE